Back to Journal
    Critical Case Report

    Vascular Occlusion Following Dermal Filler Injection: A Case Report on Emergency Management and Recovery

    HSI AI16 December 2024

    AI-Generated Summary

    This critical case report demonstrates emergency management of vascular occlusion following dermal filler injection, resulting in significant tissue necrosis. The case shows successful treatment using high-dose hyaluronidase (150-300 units), antiplatelet therapy, corticosteroids, and hyperbaric oxygen therapy at Whipps Cross Hospital. The comprehensive management approach achieved significant tissue recovery over several months, highlighting the importance of rapid recognition within 24-48 hours and multimodal emergency protocols.

    ⚠️

    Critical Emergency Protocol

    Vascular occlusion is a medical emergency requiring immediate intervention within the first 24 hours. This case report demonstrates the importance of rapid recognition, emergency management protocols, and multidisciplinary care in achieving optimal patient outcomes.

    Introduction

    Dermal fillers have become increasingly popular in aesthetic medicine, with hyaluronic acid-based fillers being the most commonly used due to their biocompatibility and reversible nature. However, despite their safety profile, serious complications can occur, with vascular occlusion being among the most feared.

    Vascular occlusion occurs when dermal filler material enters or compresses blood vessels, leading to compromised tissue perfusion and subsequent ischaemia. The incidence is reported to be between 0.05% to 0.1% of all filler procedures, but the consequences can be devastating if not promptly recognised and managed.

    🎯 High-Risk Anatomical Areas

    The perioral and nasal regions are particularly high-risk areas due to their complex vascular anatomy and the presence of end arteries with limited collateral circulation. This case report highlights the importance of immediate recognition and aggressive management of vascular occlusion.

    Case Presentation

    Patient Demographics

    Gender: Female
    Procedure: Lip enhancement with hyaluronic acid filler
    Presentation Time: 24-48 hours post-procedure
    Primary Complaint: Severe tissue discolouration and necrosis

    Initial Presentation

    🩺 Clinical Signs & Symptoms

    • Severe tissue discolouration and necrosis affecting the nasal tip and perioral region
    • Areas of tissue blanching progressing to dusky discolouration
    • Patient reporting severe pain and concern regarding tissue appearance
    • Evidence of compromised tissue perfusion with clear demarcation of affected areas

    Clinical Assessment

    Physical examination revealed extensive tissue compromise consistent with vascular occlusion. The pattern of necrosis suggested involvement of the superior labial artery and potentially the lateral nasal artery branches.

    Immediate assessment confirmed the diagnosis of vascular occlusion requiring emergency intervention. The presentation within 24-48 hours provided an optimal window for hyaluronidase effectiveness.

    Emergency Management Protocol

    Immediate Interventions

    💉 Emergency Treatment Protocol

    1
    High-dose Hyaluronidase

    150-300 units injected directly into affected tissues and along suspected filler tracks

    2
    Aspirin

    300mg loading dose followed by 75mg daily for antiplatelet effect

    3
    Corticosteroids

    Prednisolone 1mg/kg to reduce inflammatory response

    4
    Sildenafil (if appropriate)

    25mg TDS for vasodilation (contraindications assessed)

    5
    Topical Nitroglycerin

    Applied to affected areas for local vasodilation

    Rationale for Treatment Choices

    🔬 Hyaluronidase

    Remains the cornerstone of treatment for hyaluronic acid-related vascular occlusion. The enzyme rapidly dissolves hyaluronic acid, restoring vascular flow when administered within 24 hours.

    🩸 Antiplatelet Therapy

    Aspirin helps prevent further thrombotic complications and maintains microvascular perfusion in compromised tissues.

    💊 Corticosteroids

    Reduce inflammatory oedema that may further compromise tissue perfusion.

    🫀 Vasodilators

    Sildenafil and nitroglycerin enhance collateral circulation in affected tissues.

    Hyperbaric Oxygen Therapy

    Referral to Whipps Cross Hospital

    Given the extent of tissue compromise, the patient was urgently referred to Whipps Cross Hospital for hyperbaric oxygen therapy (HBOT). This represents best practice management for severe vascular occlusion cases.

    HBOT Protocol

    🏥 Hyperbaric Oxygen Treatment Protocol

    Pressure: 2.4 ATA (atmospheres absolute)
    Duration: 90 minutes per session
    Frequency: Daily sessions for first week, then alternate days
    Total treatments: 20 sessions over 6 weeks

    Mechanism of Action

    HBOT works through multiple mechanisms:

    • Increasing dissolved oxygen in plasma by up to 20-fold
    • Promoting angiogenesis and wound healing
    • Reducing tissue oedema and inflammation
    • Enhancing neutrophil bacterial killing capacity
    • Stimulating fibroblast activity and collagen synthesis

    Treatment Timeline and Response

    Time Point Clinical Findings Interventions
    0-24 hours Initial tissue blanching, pain Patient unaware of severity
    24-48 hours Dusky discolouration, necrosis evident Emergency hyaluronidase, medications initiated
    48-72 hours Necrosis demarcation clear HBOT commenced at Whipps Cross
    1 week Slight improvement in tissue colour Daily HBOT continued
    2 weeks Early granulation tissue formation Alternate day HBOT
    1 month Significant tissue recovery HBOT course completed
    3 months Near-complete healing Conservative management
    6 months Excellent cosmetic outcome Discharged from care

    Photographic Documentation

    Serial photography documented the progression from initial necrosis through to complete healing:

    📸 Early Phase (Day 1-2)

    Dusky discolouration with clear demarcation

    📸 Acute Phase (Week 1)

    Necrotic tissue with surrounding erythema

    📸 Healing Phase (Week 2-4)

    Granulation tissue formation and healing

    📸 Recovery Phase (Month 3-6)

    Progressive tissue remodelling and scar maturation

    Complications and Management

    Immediate Complications

    • Pain management: Required regular analgesia for first 2 weeks
    • Psychological impact: Significant anxiety and distress requiring support
    • Social impact: Time off work and social activities during acute phase

    Long-term Considerations

    • Scarring: Minimal residual scarring achieved with aggressive early management
    • Functional impact: No permanent functional deficits
    • Patient confidence: Gradual restoration with counselling support

    Lessons Learned

    Critical Success Factors

    🎯 Keys to Success

    1. Early recognition: Presentation within 24-48 hours was crucial
    2. Aggressive treatment: High-dose hyaluronidase and multimodal approach
    3. Specialist referral: Prompt HBOT referral enhanced outcomes
    4. Patient compliance: Adherence to medication regimen and HBOT schedule
    5. Multidisciplinary care: Coordination between aesthetic practitioner and hospital team

    Prevention Strategies

    🛡️ Prevention Protocol

    • Anatomical knowledge: Understanding of high-risk vascular territories
    • Injection technique: Aspiration, slow injection, appropriate depths
    • Product selection: Appropriate viscosity for anatomical region
    • Patient education: Recognition of early warning signs
    • Emergency preparedness: Availability of hyaluronidase and treatment protocols

    Current Evidence and Guidelines

    Recent literature supports the management approach used in this case:

    🧬 Hyaluronidase Evidence

    • Most effective within 24 hours of filler injection
    • Doses of 150-1500 units reported in literature
    • Multiple injection sites along suspected filler tracks
    • May require repeat treatments

    🏥 HBOT Evidence

    • Level II evidence for tissue necrosis and wound healing
    • Particularly beneficial when conventional treatment insufficient
    • Protocol: 2.0-2.4 ATA for 90-120 minutes
    • Course typically 20-40 treatments

    Discussion

    This case demonstrates several important principles in vascular occlusion management:

    ⏰ Time-sensitive intervention

    The effectiveness of hyaluronidase decreases significantly after 24-48 hours, making rapid recognition and treatment crucial.

    🔄 Multimodal approach

    No single intervention is sufficient; combination therapy targeting different pathophysiological mechanisms yields optimal results.

    🏥 Specialist resources

    Access to hyperbaric oxygen therapy can be life and limb-saving in severe cases, justifying the infrastructure investment.

    🧠 Patient support

    The psychological impact of vascular occlusion should not be underestimated, and appropriate counselling support is essential.

    Recommendations for Practice

    Emergency Kit Contents

    🚨 Essential Emergency Equipment

    • Hyaluronidase - minimum 300 units immediately available
    • Aspirin 300mg tablets
    • Prednisolone or equivalent corticosteroid
    • Topical GTN 2% ointment
    • Emergency contact numbers for HBOT centres
    • Clear protocols and dosing charts

    Training Requirements

    📚 Mandatory Training Components

    • Recognition of early signs of vascular compromise
    • Emergency management protocols
    • Hyaluronidase reconstitution and injection techniques
    • Referral pathways for specialist care
    • Documentation and follow-up procedures

    Conclusion

    Vascular occlusion following dermal filler injection remains a rare but serious complication that can result in permanent disfigurement if not promptly and aggressively managed. This case demonstrates that excellent outcomes are achievable with:

    • Early recognition within 24-48 hours
    • Immediate high-dose hyaluronidase treatment
    • Multimodal medical therapy
    • Prompt referral for hyperbaric oxygen therapy
    • Comprehensive patient support

    All practitioners performing dermal filler injections must be prepared to manage this emergency, with appropriate training, equipment, and referral pathways in place. The investment in emergency preparedness is justified by the potential to prevent permanent disability and restore patient confidence in aesthetic treatments.

    This case reinforces the principle that prevention remains better than cure, emphasising the importance of thorough anatomical knowledge, appropriate injection techniques, and careful patient selection in minimising the risk of vascular complications.

    Was this article helpful?

    Your feedback helps us improve our content

    Continue Your Learning

    Explore more evidence-based articles in our clinical journal

    Browse All Articles
    AI